GREENLAND MINES LTD Stock Redeemed or Called During Period, Value
GREENLAND MINES LTD (GRML) reported Stock Redeemed or Called During Period, Value of $94.88 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-17.
Discontinued › Shareholders' Equity
us-gaap:StockRedeemedOrCalledDuringPeriodValue · last filed 2024-04-17
- GREENLAND MINES LTD stock redeemed or called during period, value for the quarter ending 2022-06-30 was $96.34M.
- GREENLAND MINES LTD stock redeemed or called during period, value for the quarter ending 2022-03-31 was $25.00K.
- GREENLAND MINES LTD stock redeemed or called during period, value for fiscal 2022 was $94.88M.
| Period end | Stock Redeemed or Called During Period, Value 3 month | Stock Redeemed or Called During Period, Value 3 month as first filed | Stock Redeemed or Called During Period, Value 6 month | Stock Redeemed or Called During Period, Value 12 month | Stock Redeemed or Called During Period, Value 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $94.88M 10-K · filed 2024-04-17 | $6.90M 10-K · filed 2023-04-10 | |||
| 2022-06-30 | $96.34M 10-Q · filed 2023-11-17 | $6.90M 10-Q · filed 2022-08-15 | $96.36M derived: sum of 2 quarters · filed 2023-11-17 | ||
| 2022-03-31 | $25.00K 10-Q · filed 2023-05-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |